Simcere Pharmaceutical Group Limited (2096.HK)

HKD 8.99

(2.63%)

Operating Income Summary of Simcere Pharmaceutical Group Limited

  • Simcere Pharmaceutical Group Limited's latest annual operating income in 2023 was 711.8 Million CNY , down -17.47% from previous year.
  • Simcere Pharmaceutical Group Limited's latest quarterly operating income in 2024 Q2 was 246.08 Million CNY , down 0.0% from previous quarter.
  • Simcere Pharmaceutical Group Limited reported an annual operating income of 862.5 Million CNY in 2022, up 25.38% from previous year.
  • Simcere Pharmaceutical Group Limited reported an annual operating income of 687.9 Million CNY in 2021, up 21.61% from previous year.
  • Simcere Pharmaceutical Group Limited reported a quarterly operating income of 246.08 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Simcere Pharmaceutical Group Limited reported a quarterly operating income of -800.1 Million CNY for 2023 Q4, down -554.63% from previous quarter.

Annual Operating Income Chart of Simcere Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Operating Income of Simcere Pharmaceutical Group Limited (2023 - 2012)

Year Operating Income Operating Income Growth
2023 711.8 Million CNY -17.47%
2022 862.5 Million CNY 25.38%
2021 687.9 Million CNY 21.61%
2020 565.66 Million CNY -51.71%
2019 1.17 Billion CNY 24.35%
2018 941.94 Million CNY 77.53%
2017 530.57 Million CNY 0.0%
2012 96.36 Million CNY 0.0%

Peer Operating Income Comparison of Simcere Pharmaceutical Group Limited

Name Operating Income Operating Income Difference
Uni-Bio Science Group Limited 67.76 Million HKD -950.351%
CK Life Sciences Int'l., (Holdings) Inc. 897.95 Million HKD 20.731%